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Abstract: Tiamulin is a semisynthetic pleuromutilin antibiotic that binds to the 50S ribosomal subunit
A site and whose (((2-diethylamino)ethyl)thio)-acetic acid tail extends into the P site to interfere
with peptide bond formation. We have isolated spontaneous tiamulin-resistant mutants of the
thermophilic bacterium Thermus thermophilus, containing either single amino acid substitutions in
ribosomal protein uL3 or single base substitutions in the peptidyltransferase active site of 23S rRNA.
These mutations are consistent with those found in other organisms and are in close proximity to the
crystallographically determined tiamulin binding site. We also conducted a cross-resistance analysis
of nine other single-base substitutions in or near the peptidyltransferase active site, previously
selected for resistance to structurally unrelated antibiotics. While some of the base substitutions
in 23S rRNA are positioned to directly affect tiamulin-ribosome contacts, others are some distance
from the tiamulin binding site, indicating an indirect mechanism of resistance. Similarly, amino
acid substitutions in uL3 are predicted to act indirectly by destabilizing rRNA conformation in the
active site. We interpret these observations in light of the available ribosome X-ray crystal structures.
These results provide a more comprehensive profile of tiamulin resistance caused by mutations in the
bacterial ribosome.
Keywords: tiamulin; peptidyltransferase; ribosome; rRNA; ribosomal protein; antibiotic resistance
mutation; Thermus thermophilus
1. Introduction
The ribosomal peptidyltransferase active site (also referred to as the PTC), the site of peptide
bond formation during protein synthesis, is the target of a number of structurally unrelated classes
of antibiotics, and mutations conferring resistance to many of these drugs have been identified in
the genes encoding 23S rRNA or ribosomal proteins from a wide range of organisms. Advances in
structural biology have led to numerous high-resolution structures of ribosomes in complex with
antibiotics, providing a wealth of information about the mechanisms of action of these important drugs
and facilitating predictions about mechanisms of antibiotic resistance reviewed by [1–3].
The pleuromutilin class of antibiotics, the first of which was isolated from the fungus Pleurotus
mutilis [4], includes the semi-synthetic derivatives tiamulin, repatamulin, and valnemulin, and are
used primarily in veterinary medicine reviewed by [5]. Based on chemical footprinting of 23S rRNA in
Escherichia coli ribosomes, pleuromutilins bind to the PTC and compete for binding with the 16-atom
macrolide and peptidyltransferase inhibitor carbomycin (though not with the 14-atom macrolide
erythromycin) [6], and thereby inhibit peptide bond formation [7]. The precise nature of pleuromutilin
binding to the ribosome was subsequently determined by X-ray crystallography of ribosome–drug
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complexes [8–10]. Tiamulin interacts exclusively with rRNA residues, although ribosomal protein uL3
is in close proximity to the tiamulin binding site without making direct contact with the drug.
Tiamulin-resistant mutants with altered ribosomal proteins were first identified in E. coli, although
the exact nature of the mutations was not determined [11]. Subsequent studies of several organisms,
including E. coli [12,13], Brachyspira spp. [14], and Staphylococcus aureus [15,16], found resistance to
result from amino acid substitutions in ribosomal protein uL3. Ribosomal protein uL3 consists of a
globular domain situated on the 50S subunit surface, and an extended loop that reaches deep into
the subunit where it approaches the PTC [17–20]. Amino acid substitutions conferring tiamulin
resistance occur in this loop and presumably confer resistance by affecting local rRNA conformation.
Resistance results from reduced binding, as indicated by chemical footprinting of mutant ribosomes
from Brachyspira spp. [14]. Consistent with chemical probing data, tiamulin-resistance also results
from base substitutions in 23S rRNA in and around the PTC of several organisms, including E. coli [12],
Brachyspira spp. [14], S. aureus [16], Mycobacterium smegmatis [21], and Mycoplasma gallisepticum [22].
Both the chemical probing data and the nature of mutations can to some extent be rationalized
given the X-ray crystal structures of pleuromutilins in complex with ribosomes from either the
bacterium Deinococcus radiodurans [8,9] or the archaeon Haloarcula marismortui [10]. Several base
substitutions in 23S rRNA occur at sites of drug contact and presumably lead to reduced binding
affinity. Amino acid substitutions in uL3 occur at residues in close proximity to some of these same
23S rRNA residues, suggesting indirect effects on RNA conformation as the mechanism of resistance.
While binding of pleuromutilins protects some bases (U2506, U2584, U2585) in close proximity to the
drug from chemical probes, it enhances reactivity of others (A2058 and A2059), more distant from the
drug binding site, suggesting that drug binding can induce conformational changes [6]. It also suggests
that substitutions of bases not in the immediate vicinity of tiamulin could confer drug resistance by
indirect means.
In order to more extensively characterize the basis for pleuromutilin resistance, we isolated
spontaneous tiamulin-resistant mutants of the thermophilic bacterium Thermus thermophilus and tested
for cross-resistance to tiamulin a number of mutants with base substitutions in the PTC previously
selected for resistance to other antibiotics [23]. This organism has proven to be a good model system
for the study of antibiotic-resistance mutations with the ability to combine facile genetics, biochemistry,
and crystallography of its ribosomes [24]. Building upon previous studies, these data provide a more
comprehensive examination of tiamulin-resistance. By examining published crystal structures of
tiamulin bound to the 50S subunit of D. radiodurans [8] and H. marismortui [10], we assess the likely
mechanism of resistance caused by these mutations. While base substitutions occur in the tiamulin
binding pocket, others are located some distance away, supporting the hypothesis that pleuromutilin
resistance can be caused by conformational changes due to mutations distant from the drug binding
site, and that these mutations distort ribosome conformation.
2. Results
2.1. Isolation of Spontaneous Tiamulin-Resistant Mutants
In order to maximize the range of mutants arising in selections, we employed two different
T. thermophilus strains, HB27 [25] and IB-21 [26], originally isolated from locations geographically remote
from one another (Japan and Iceland, respectively) and having different optimal growth temperatures.
These strains both contain two copies of each rRNA gene, but rapid gene conversion generally results in
homoallelic mutants producing pure populations of mutant ribosomes [23]. We noted that temperature,
strain, drug concentration, and media formulation, are all variables potentially influencing the spectrum
of mutations isolated (our unpublished observations). We therefore selected tiamulin-resistant mutants
at either 65 or 72 ◦C and at 50, 100, or 200 µg/mL. Mutants and their selections are listed in Table 1.
Based on the known binding site of tiamulin in the PTC, as well as previously described tiamulin-
resistant mutants, we PCR amplified and sequenced the corresponding regions of the rrlA and rrlB
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genes encoding 23S rRNA and the rplC gene encoding ribosomal protein uL3. We identified two
mutations in rplC, CGC to either CAC or TGC, that result in either of two amino acid substitutions at the
same position, R149H or R149C of uL3 (E. coli numbering used throughout; corresponding to R144 in
the T. thermophilus sequence; Figure 1a). These were selected on 50 and 100 µg/mL tiamulin. Amino acid
substitutions at this and surrounding positions have been identified in other species [12–16]. We also
identified a total of six different base substitutions in the 23S rRNA in the PTC. Among these were
G2061A, G2061U, A2451U, C2452U, U2500A, and U2504G. We had previously identified several of these
(G2061A, C2452U, U2500A, and U2504G) in selections for mutants resistant to chloramphenicol [23],
but have not previously observed the G2061U and A2451U substitutions in T. thermophilus. A2451U is
particularly noteworthy as having been described previously only in mouse mitochondria [27] and
Mycobacterium smegmatis [28].
Table 1. Spontaneous tiamulin-resistant mutants identified in this study.
Strain Genotype Mutation Tiamulin Selection Temperature
IB-21 rplC-R149H uL3-R149H 50 µg/mL 72 ◦C
IB-21 rplC-R149C uL3-R149C 100 µg/mL 72 ◦C
HB27 rplC-R149C uL3-R149C 100 µg/mL 72 ◦C
IB-21 rrlAB-G2061A 23S-G2061A 50, 100 µg/mL 72 ◦C
HB27 rrlAB-G2061A 23S-G2061A 100 µg/mL 65 ◦C
IB-21 rrlAB-G2061U 23S-G2061U 100 µg/mL 62 ◦C
HB27 rrlAB-G2061U 23S-G2061U 100 µg/mL 72 ◦C
HB27 rrlAB-A2451U 23S-A2451U 100 µg/mL 72 ◦C
IB-21 rrlAB-C2452U 23S-C2452U 50 µg/mL 72 ◦C
IB-21 rrlAB-U2500A 23S-U2500A 100, 200 µg/mL 72 ◦C
HB27 rrlAB-U2500A 23S-U2500A 50 µg/mL 65 ◦C
IB-21 rrlAB-U2504G 23S-U2504G 100 µg/mL 62 ◦C
HB27 rrlAB-U2504G 23S-U2504G 200 µg/mL 72 ◦C
E. coli numbering used throughout. Mutants were selected on TMG medium containing tiamulin at the indicated
concentrations and at the temperature indicated.
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Figure 1. Sites of mutations and inferred mechanisms of resistance. (A) Sequence alignment of ribosomal
protein uL3 encompassing the sites of mutations identified in this study. Uses organisms for whom
tiamulin-resistance mutations in uL3 have been found. Tth, Thermus thermophilus (Accession number
Q72I04); Dra, Deinococcus radiodurans (Accession number Q9RXK2); Eco, Escherichia coli (Accession
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number P60438); Sau, Staphylococcus aureus (Accession number P60449); Bhy, Brachyspira hyodysenteriae
(Accession number A0A2K9JGD3) (B) Interaction of ribosomal protein uL3 and 23S rRNA at the
tiamulin binding site, based on the crystal structures of ribosomes from T. thermophilus (PDB entry
4y4p.cif; 36) and D. radiodurans (PDB entry 1xbp.cif; 8). Structures were aligned and images rendered
using PyMOL (Schrodinger). R149 is within hydrogen bonding distance of the 2’ hydroxyl of U2504 and
the phosphate oxygen of U2506. (C) Interactions between tiamulin and 23S rRNA in the D. radiodurans
(PDB entry 1xbp.cif; 8) 50S subunit structure. Sites of mutation conferring resistance are colored red,
sites of mutations not conferring resistance are colored blue.
To demonstrate a direct causal relationship between mutation and resistance phenotype, wild-type
T. thermophilus was transformed with genomic DNA from the resistant mutants, selecting tiamulin
resistance and then confirming the presence of the original mutation by sequencing. In all cases,
transformants contained the originally selected tiamulin-resistance mutation, indicating a causal
relationship between mutation and phenotype.
2.2. Resistance Phenotypes
We estimated comparative resistance to tiamulin using a disc diffusion assay (Table 2; see Section 4).
As controls, assays were also performed using the 30S subunit antibiotic streptomycin, the DNA
gyrase inhibitor ciprofloxacin, and the cell wall synthesis inhibitor ampicillin. These analyses provide
a crude, semi-quantitative measure of relative drug resistance. Ribosomal protein uL3 mutants
conferred the lowest level of tiamulin resistance, exhibiting significant inhibition zones, while all of the
23S rRNA mutants were generally more resistant. For instance, G2061A, G2061U, A2451U, U2500,
and U2504G showed no zones of inhibition. The possibility that lack of inhibition due to thermal
degradation of tiamulin during prolonged incubation of slow-growing mutants can be excluded
since discs pre-incubated at 72 ◦C for 1 week show no decrease in inhibition zone against wild-type
T. thermophilus.
Table 2. Cross-resistance phenotypes of tiamulin-resistant mutants.
Mutant
Zone of Inhibition (mm)
Tam Ery Clr Rox Azm Mid Tyl Spi Lin Chl Str Rif Amp Cip
WT (IB-21) 30 27 36 32 22 21 36 16 36 29 14 17 40 22
WT (HB27) 32 29 36 33 25 24 37 15 41 33 16 - 38 21
uL3-R149H 16 23 33 28 18 25 39 10 44 38 15 17 45 20
uL3-R149C 17 25 36 32 22 23 38 12 35 31 17 16 51 25
23S-G2061A - 42 63 65 34 46 71 40 34 - 20 27 55 28
23S-G2061U - 22 35 24 11 24 48 13 7 9 17 17 50 25
23S-A2451U - 12 33 28 15 28 64 27 - - 30 21 50 26
23S-C2452U - 14 25 20 10 20 48 13 20 9 16 15 42 22
23S-U2500A - 14 20 19 11 12 36 7 18 15 15 17 40 21
23S-U2504G - 18 34 28 13 18 46 16 22 - 16 16 42 22
All mutants are derived from IB-21 with the exception of the 23S rRNA-A2451U mutant, which is derived from
HB27. Additionally, included are mutants obtained in a previous study, all derived from IB-21. Tam, tiamulin;
Ery, erythromycin; Clr, clarithromycin; Rox, roxithromycin; Azm, azithromycin; Mid, midecamycin; Tyl, tylosin;
Spi, spiramycin; Lin, lincomycin; Chl, chloramphenicol; Str, streptomycin; Rif, rifampicin; Amp, ampicillin; Cip,
ciprofloxacin. Discs were 6 mm, such that a zone of 6 mm indicates no inhibition (indicated by -). Due to the high
frequency of reversion, the G2061A mutant was grown in the presence of chloramphenicol. Blue, strong resistance
(complete or nearly complete absence of inhibition zone); light blue, weak resistance (50% or greater reduction in
inhibition zone).
We examined the cross-resistance phenotypes of PTC mutants to various 50S subunit inhibitors
binding at or near the peptidyltransferase active site. In addition to tiamulin, we tested sensitivity
to the 14-atom macrolides erythromycin, clarithromycin, roxithromycin, the 15-atom macrolide
azithromycin, the 16-atom macrolides midecamycin, tylosin, and spiramycin, the lincosamide
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lincomycin, and chloramphenicol. Ampicillin and the DNA gyrase inhibitor ciprofloxacin were
included for comparison. Results from these tests are shown in Table 2.
The uL3 mutations produce no cross resistance to other drugs that bind to this region and were
specific for tiamulin. We previously identified chloramphenicol-resistant or macrolide-resistant mutants
of T. thermophilus containing single base substitutions in the vicinity of the PTC [23]. As several of these
same base substitutions were identified in selections for tiamulin-resistant mutants in the current study,
we examined a number of available PTC mutants for resistance to tiamulin. These included A2058G,
A2059G, G2447A, A2453G, U2500C, A2503G, U2504C, U2504A, and G2505A. Of these, the only ones
found to confer tiamulin resistance were G2447A and U2504A, which confer weak resistance (16 and
17 mm zones of inhibition, respectively), at levels comparable to those produced by the uL3 mutations.
Since U2504 was identified in our initial selections, only G2447A was not identified in selections for
tiamulin resistance. This suggests that our initial selections were close to exhaustive.
2.3. Resistance to Other PTC-Binding Antibiotics
A large number of antibiotics target the PTC, and we examined our tiamulin-resistant mutants
for cross-resistance to a broad range of drugs. Most notable is the consistent hypersensitivity of
the G2061A mutant to macrolides, but not to tiamulin, lincomycin, or chloramphenicol. While this
could be accounted for as a result of the extremely slow growth rate of this mutant, the A2451U
mutant does not show this same level of hypersensitivity, despite also being very slow growing. This
latter mutant shows hypersensitivity to the 16-atom macrolide tylosin and resistance to lincomycin
and chloramphenicol. The isolation of A2451U as a tiamulin-resistance mutation showing cross
resistance to chloramphenicol is perhaps significant as base substitutions at A2451 have previously
been isolated as chloramphenicol-resistance mutations in mouse mitochondria [27] and found to confer
chloramphenicol resistance after site-directed mutagenesis of Mycobacterium smegmatis [28].
Base substitutions at U2504 produce varying phenotypes, depending on the actual base
substitution. Thus, U2504G confers complete tiamulin resistance (and was identified as a spontaneous
tiamulin-resistant mutant), while U2504A confers minimal resistance and U2504C confers no resistance
at all. Base substitutions at U2504 also exhibit varied responses to either lincomycin or the 16-atom
macrolide tylosin, with U2504G conferring resistance, U2504C conferring only weak resistance,
and U2504A conferring hypersensitivity. In contrast, all three base substitutions confer chloramphenicol
resistance and were previously identified in selections for chloramphenicol resistance [23].
3. Discussion
Amino acid substitutions in uL3 conferring tiamulin resistance have been found in several
organisms, including E. coli, S. aureus, and Brachyspira spp. Currently there are crystal structures of
tiamulin bound to ribosomes from two sources, D. radiodurans [8] and H. marismortui [10]. In neither
case is uL3 positioned to make direct contact with tiamulin (Figure 1b), indicating that the mechanism
of resistance conferred by uL3 mutations is indirect, presumably via some perturbation of rRNA
conformation. While the D. radiodurans structure does not show sidechains for ribosomal protein
uL3 [8], structures of the T. thermophilus ribosome shows the δ-guanidinium group of R149 of uL3 to be
within 3 Å of a phosphate oxygen of U2506 of 23S rRNA [29]. A site-directed mutagenesis study of
E. coli uL3 [13] found that, while N149S and N149D substitutions confer resistance (the latter confirming
previous studies of spontaneous mutants), N149R does not, consistent with the presence of an arginine
at this position in the wild-type T. thermophilus uL3. However, examination of the crystal structure of
the E. coli ribosome [20] or the cryo-EM structure of the S. aureus ribosome [30] indicates that neither
the asparagine residue at position 149 of E. coli nor the alanine at position 149 of S. aureus uL3 are
in position to make a direct contact with 23S rRNA. Other amino acid substitutions found in uL3 of
tiamulin-resistant S. aureus are R141S, G147R, A149L, S150L, and D151Y [15,16]. Therefore, the means
by which mutations at N149 of E. coli or A149 of S. aureus uL3 confer resistance is not clear, as neither
of these residues are in position to interact with 23S rRNA as does the arginine in T. thermophilus uL3.
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All of the base substitutions conferring tiamulin resistance occur at universally or nearly universally
conserved positions (Table 3), suggesting that each of these residues plays an important role in catalysis,
rRNA folding, or stabilizing the structure in a catalytically active conformation. It therefore follows that
base substitutions in the active site could perturb the structure sufficiently to impact tiamulin binding
affinity. There is currently no crystal structure of the T. thermophilus ribosome in complex with tiamulin,
so structural interpretations are based on examination of crystal structures of the D. radiodurans [8] and
H. marismortui [10] 50S subunit–tiamulin complexes.
Table 3. Closest approaches of 23S rRNA bases and tiamulin.
Mutation TiamulinPhenotype 1 Conservation Nearest Neighbor
Distance
(Dra, Å)
Distance
(Hma, Å)
A2058G S 98.33/42.28 A2058-N6:Tam-O2 7.1 7.1
A2059G S 99.17/99.41 A2059-N1:Tam-O2 6.7 5.8
G2061A,U R,R 100.00/99.88 G2061-N2:Tam-O4 3.0 3.0
G2447A R 96.28/98.20 G2447-N1:Tam-C8 5.3 5.0
A2451U R 100.00/100.00 A2451-N6:Tam-C7 3.6 3.3
C2452U R 100.00/100.00 C2452-C1’:Tam-O1C2452-O2:Tam-O1
3.9
4.0
4.7
2.9
A2453G S 99.59/82.39 A2453-N3:Tam-C2 6.0 6.6
U2500A,C R,S 100.00/99.64 U2500-O2:Tam-C1U2500-O2:Tam-C2
7.2
7.4
6.4
6.1
A2503G S 99.59/98.31 A2503-O2’:Tam-C17A2503-C8:Tam-O2
3.0
-
4.0
3.0
U2504G,C,A R,S,R 99.59/98.43 U2504-C5:Tam-C1U2504-O2’:Tam-C2
3.5
5.0
5.6
3.0
1S, sensitive; R, resistant. Distance based on PDB entries 1xbp.cif for D. radiodurans (Dra) [8] and 3g4s.cif for
H. marismortui (Hma) [10].
While the exact effects of base substitutions on the structure of rRNA in the PTC are difficult to
predict, all the mutants are viable, indicating that the conformation of the mutant active sites must
sufficiently resemble the native structure to permit catalysis of peptide bond formation. What the
crystal structures do provide is an approximation of the closest approach of mutated residues and
tiamulin (Table 3). While some differences between the two structures are evident, some interpretation
regarding mechanisms of resistance is still possible.
There is a rough correlation between the proximity of mutated residues to tiamulin and the
resistance phenotype; mutated residues near the tiamulin binding site are more likely to cause resistance
than mutated residues at more remote positions (Figure 1c). Thus, substitutions at A2058 and A2059,
which are between 6 and 7 Å from tiamulin, fail to confer resistance, leaving unresolved the question
of enhanced chemical reactivity of A2058 upon tiamulin binding [6]. It is worth noting that U2504G
confers resistance to both tiamulin and chloramphenicol, while disrupting the contact of uL3 with the
nearby U2506 confers only tiamulin resistance, suggesting that the latter mutation has less of an impact
on the local structure. This is also consistent with the higher level of tiamulin resistance conferred by
the U2504G substitution.
A2451 is the 23S rRNA residue closest to the site of peptide bond formation, as first revealed by the
crystal structure of the H. marismortui 50S subunit [31]. A2451 is a universally conserved nucleotide [32]
and only two other instances of viable mutants having base substitutions at this position have been
reported [27,28]; substitutions at A2451 produce dominantly lethal phenotypes in Escherichia coli [33].
A2451 is under 4 Å from tiamulin but does not appear to make direct contact. A2503G and G2505A,
originally isolated as chloramphenicol-resistance mutations, do not confer tiamulin resistance despite
being within 3 Å of tiamulin. The nearest approach to tiamulin by A2503 is via the C8, and would
thus not be influenced by an A to G transition. The nearest approach from G2505 is via the backbone,
and similar would not necessarily be affected by a base substitution.
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Several of the mutations cannot be explained by direct loss of antibiotic–ribosome contact. G2447’s
closest approach to tiamulin is about 5 Å and U2500 roughly 7 Å. Substitutions at these positions could
perturb the structure sufficiently to diminish binding without propagating throughout the active site,
and thereby having drastic effects on peptide-bond forming ability. The ability of base substitutions
in the PTC to confer resistance despite being remote from the drug binding site has been observed
before [34,35]. The idea that pleuromutilins bind via an induced-fit mechanism has been proposed
based on X-ray crystal structures [35]. The enhanced reactivity of A2058 to chemical probes suggests
an indirect influence of tiamulin on the conformation of these residues. These observations further
emphasize the ability of antibiotic-resistance mutations to exert their effects from a position remote
from the antibiotic binding site. More detailed structural analyses will be necessary to uncover the
precise basis for resistance caused by individual mutations.
4. Materials and Methods
4.1. Bacterial Strains and Cultivation
All mutants were derived from the T. thermophilus strains HB27 (ATCC BAA-163) [25] or IB-21 [26].
All strains were grown in TEM (Thermus Enhanced Medium, ATCC Medium 1598) or plated on TMG
medium (identical to TEM with the exception of 0.5 g/L CaCl2 and lacking phosphate buffer) solidified
with Gellam Gum (PlantMedia). Antibiotics were from the author’s collection or were purchased from
Sigma-Aldrich Chemical Corp.
4.2. Isolation of Spontaneous Mutants
To isolate mutants, overnight cultures originating from single colonies were grown in TEM
overnight to saturation, and 109 cells were plated onto TMG plates containing tiamulin at 50, 100,
or 200 µg/mL. Mutants derived from either of the two T. thermophilus strains, IB-21 or HB27, were
isolated at 62, 65, or 72 ◦C. After several days, mutant colonies appearing on selection plates were
streaked for isolation on the same selection medium. Colonies arising on restreaks were streaked
a second time on TMG plates without antibiotic. Single colonies were used to inoculate overnight
cultures in TEM, grown to saturation, archived as glycerol stocks, and harvested for genomic DNA
preps using the Wizard Genomic DNA kit (Promega) or the PureLink genomic DNA kit (Invitrogen).
4.3. Analysis of Mutants
PCR amplification of the rplC locus or the PTC region of rrlA and rrlB was performed using
OneTaq DNA Polymerase (New England Biolabs). The rplC locus encoding ribosomal protein uL3
was amplified using oligonucleotide primers (IDT) Tth_rplC-fwd1 (5′-GAGCACTTTGAGCTGCGC
ACCCACAACC-3′) and Tth_rplC-rev2 (5′-GTGTGCTTCTGCG GCCAGATCTTCCGGC-3′) and
sequenced using primers Tth_rplC-fwd1 and Tth_rplC_rev1. The rrlA and rrlB loci were amplified
using primer pair Tth-23S-E (5′-CGCCAAGGAACTCTGCAAGTTGGC-3′) and Tth-23S-F (5′-CCAGA
GGTGCGTCCCTTCCG GTCC-3′) and sequenced using primers Tth-23S-E and Tth-23S-F. Sequencing
was performed at the University of Rhode Island Genomics and Sequencing Center.
To confirm that the mutations identified by sequencing were actually responsible for the resistance
phenotypes, wild-type T. thermophilus was transformed with genomic DNA, selecting the original
phenotype. Transformants were purified, gDNA was extracted, and the presence of the original
mutations were confirmed by PCR and sequencing.
4.4. Disc Diffusion Assays
To measure antibiotic resistance, 100 µL of a saturated overnight culture (approximately 108
cells) was plated onto a series of TMG plates. Onto the center of each plate was placed a 6 mm
filter-paper disc (Whatman No. 2017-006) containing antibiotic. Concentrations used were as
follows: tiamulin, erythromycin, clarithromycin, roxithromycin, azithromycin, midecamycin, tylosin,
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spiramycin, lincomycin, chloramphenicol, streptomycin, rifampicin, ciprofloxacin all 100 µg; and
ampicillin, 20 µg. Plates were incubated overnight at 65 or 72 ◦C. The diameter of zones of inhibition
were measured in millimeters.
5. Conclusions
The results described here provide a more comprehensive description of tiamulin-resistance
mutations than previously observed in a single system. Given the amenability of ribosomes from
T. thermophilus to crystallization and structure determination, these mutants should provide an
important resource for establishing the precise mechanism of resistance to tiamulin at the atomic level.
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